This article is for education purposes only, and not to be taken as advice to buy/sell. Please do your own due diligence before committing to any trade/investment.
Is President Donald Trump serious about taking over Greenland?
The US began bombing and storming boats and ships in Venezuela months before invading the country and removing its president by force.
But taking over Greenland by force could be a lot more complicated given that Denmark and its allies could band together, resulting in devastation, or even weaken the US, something that’s not pleasant for the US.
With this geopolitical uncertainty in Europe and elsewhere, the stock market is likely to be more volatile than usual. However, with a trading plan and system, navigating the stock market can be easier.
Using our proprietary trading system, I’ve uncovered a position trading opportunity for this stock – Glaukos.
Brief History of Glaukos
Source: investors.glaukos.com/events-and-presentations/Presentations/default.aspx
Glaukos is a healthcare company founded in 1998.
The company develops and sells novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
Glaukos has been highly innovative, developing new solutions and implementing them successfully repeatedly.
Expansion has also been on the company’s mind, and it took some time before it established a presence in 17 countries and counting.
As the company continues to find new therapies and solutions, are its shares worth buying for a position trade?
Business Model and Financials
Source: tradingview.com
Let’s look at 2 key metrics from the image above – total revenue (in blue) and net income (in yellow).
Did you notice that the total revenue of Glaukos grew every year except for 2020 and 2022?
This consistent increase in its total revenue is highly welcomed in any sector.
Here’s another important fundamental metric to consider: net income.
Can the same be said of its net income?
Glaukos’ net income has been swinging like a pendulum, but without clear rhythm. This is normal for healthcare companies that focus on research and constantly finding new medical solutions. Therefore, I think that there’s no cause for concern regarding its net income.
Are these strong enough reasons to consider buying the shares of Glaukos for a position trade?
Let’s have a look at its stock chart to provide more clarity.
Technical Analysis on Glaukos (NYSE: GKOS)
This is the chart of Glaukos’ stock.
What can you infer from it?
I can tell that Glaukos’s shares were in a downtrend for some time until Nov 2025. When the bears are in charge, you’ll see more red candles (outlined and solid) compared to those in blue.
The situation changed when Nov 2025 arrived. The bulls woke up and took charge, pushing prices higher.
Knowing this, I’ll look for a buying opportunity.
Do I need to plot support and resistance, trendlines, or slap on other indicators to help you determine the right time to buy its shares for a position trade?
Nope, I don’t have to.
All I need to do is refer to the 2 proprietary indicators – the green arrow and Trend Impulse Factor.
When there’s a green arrow under a blue (outlined or solid) candle, it signals a fresh bullish move. Do you see it under its latest candle?
Let’s turn our attention to the other proprietary indicator – Trend Impulse Factor.
The Trend Impulse Factor indicator is curated to inform traders whether the move in the market is likely to be sustainable, giving you and I an edge.
When the bar of the Trend Impulse Factor indicator is dark green in color, it suggests that this bullish move is likely to be sustained. Now, let’s have a look at the color of the Trend Impulse Factor indicator’s bar.
It’s not dark green in color yet, suggesting that the time to buy its shares for a position trade isn’t ripe yet.
However, I think that it’s about to turn dark green in the coming days or so, so I’ll be watching this stock extra closely.
Conclusion
After a moment of peace and stability, the US stock market is turning volatile again. This is no thanks to President Donald Trump.
Instead of staying out of the stock market, I’ve scanned the market for a reliable position trading candidate using the TradersGPS (TGPS) system.
Glaukos is an exciting healthcare company that is deeply invested in solutions related to vision and the eye. It boasts a growing revenue and its future looks bright. I’m optimistic.
But should I buy its shares now?
Both the arrow and Trend Impulse Factor indicators have been tested and proven. They form the TradersGPS (TGPS) system to help you decipher if a stock is ripe for a position trade. You won’t have to feel in the dark and make wild guesses.
Relying on the green arrow and the color of its Trend Impulse Factor indicator, I can tell that its shares are not ripe for a position trade for now.
However, I’ll keep this stock in my watchlist because I anticipate an entry appearing soon.
What are your thoughts?
Share your thoughts with me below!
